These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5081366)

  • 1. Serum dopamine- -hydroxylase (D H) activity and affective states.
    Shopsin B; Freedman LS; Goldstein M; Gershon S
    Psychopharmacologia; 1972; 27(1):11-6. PubMed ID: 5081366
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.
    Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W
    Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine phosphokinase activity in newly admitted psychiatric patients.
    Gosling R; Kerry RJ; Orme JE; Owen G
    Br J Psychiatry; 1972 Oct; 121(563):351-5. PubMed ID: 5077090
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine-beta-hydroxylase in nerve function and mental illness.
    Brown FC; Coleman JH
    Dis Nerv Syst; 1975 Jul; 36(7):383-5. PubMed ID: 1097223
    [No Abstract]   [Full Text] [Related]  

  • 5. Manifest psychopathology and serum creatine phosphokinase: a correlational study.
    Guterman A
    Dis Nerv Syst; 1973 Jan; 34(1):49-53. PubMed ID: 4709192
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol.
    Markianos ES; Nyström I; Reichel H; Matussek N
    Psychopharmacology (Berl); 1976 Nov; 50(3):259-67. PubMed ID: 826971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on dopamine beta hydroxylase in serum].
    Markianos E; Nyström I
    Arzneimittelforschung; 1974 Jul; 24(7):1021-3. PubMed ID: 4603858
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
    Meltzer HY; Cho HW; Carroll BJ; Russo P
    Arch Gen Psychiatry; 1976 May; 33(5):585-91. PubMed ID: 1267575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of changed monoamine oxidases in patients with psychiatric diseases].
    Demisch L
    Nervenarzt; 1982 Aug; 53(8):455-60. PubMed ID: 7133246
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
    Murphy DL; Wyatt RJ
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders.
    Wetterberg L; Aberg H; Ross SB; Frödén O
    Scand J Clin Lab Invest; 1972 Nov; 30(3):283-9. PubMed ID: 4264461
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on dopamine-beta-hydroxylase in mental disorders.
    Goldstein M; Freedman LS; Ebstein RP; Park DH
    J Psychiatr Res; 1974; 11():205-10. PubMed ID: 4282385
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression.
    Sapru MK; Rao BS; Channabasavanna SM
    Acta Psychiatr Scand; 1989 Nov; 80(5):474-8. PubMed ID: 2596346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase.
    Rogeness GA; Maas JW; Javors MA; Macedo CA; Harris WR; Hoppe SK
    J Am Acad Child Adolesc Psychiatry; 1988 Jan; 27(1):121-5. PubMed ID: 3343196
    [No Abstract]   [Full Text] [Related]  

  • 18. Human serum dopamine-beta-hydroxylase: relationship to sympathetic activity in physiological and pathological states.
    Goldstein M; Freedman LS; Ebstein RP; Park DH; Kashimoto T
    Adv Biochem Psychopharmacol; 1974; 12(0):105-19. PubMed ID: 4278829
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum dopamine-beta-hydroxylase activity in psychotic and nonpsychotic major depression: the importance of distinguishing between unipolar and bipolar disorder.
    Rihmer Z; Arato M
    Acta Psychiatr Scand; 1990 Jul; 82(1):93-4. PubMed ID: 2399830
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.